Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
07/2006
07/05/2006CN1795910A Chinese traditional medicine preparation for treating pelvic inflammatory disease
07/05/2006CN1795852A Suppository of Metronidazole and preparation technique
07/05/2006CN1262643C Monocolone antibody, encoding gene, its uses and hybrid nodule cell line for cecreting same
07/05/2006CN1262560C 4-halogenated 17-methylene steroids, method for production thereof and pharmaceutical compositions contg. these compounds
07/05/2006CN1262547C Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative
07/05/2006CN1262540C Bicycle androgen and progesterone receptor modulator compounds and methods
07/05/2006CN1262306C Medicine tea with function of raising immunity, resisting fatigue and preventing impotence and prospermia
07/05/2006CN1262303C Mastitis treating medicine
07/05/2006CN1262296C Medicine composition, preparing method and use for preparing gynecological medicine
07/05/2006CN1262292C Medicine composition, preparing method and use for preparing gynecological medicine
07/04/2006US7071344 Vitamin D derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
07/04/2006US7071234 Administering racemic or optically pure sibutramine metabolite, or a pharmaceutically acceptable salt, solvate, or clathrate for prophylaxis or therapy
07/04/2006US7071221 Heterocyclic oxime compounds
07/04/2006US7071207 Suppression appetite; induction weight loss
07/04/2006US7071202 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
07/04/2006US7071195 Especially amino- or amido-ethyltetralin derivatives
07/04/2006US7071185 Treating schizophrenia with no weight-gain side effects; 5-HT2c recptor agonist; bipolar disorder; antidepressants; anxiolytic agents; panic attack; agoraphobia; antiepileptic agents; sleep disorders; migraines; sexual dysfunction
07/04/2006US7071170 Bactericides; antiprotozoa agents
07/04/2006US7070793 Antigen protein and nucleic acid coding for said protein
07/04/2006US7070766 Delivery of physiologically active compounds through an inhalation route
07/04/2006US7070765 condensation aerosol formed by heating a thin layer containing the ester, on a solid support to produce a vapor of the ester, and condensing the vapor; less than 10% ester degradation products by weight, and a Mass median aerodynamic diameter of less than 5 microns.
07/04/2006US7070764 Delivery of analgesics through an inhalation route
07/04/2006US7070763 Delivery of diphenhydramine through an inhalation route
07/04/2006US7070762 Delivery of analgesics through an inhalation route
07/04/2006US7070761 Aerosols; heating, vaporization, cooling
07/04/2006CA2264721C A1 adenosine receptor antagonists
06/2006
06/29/2006WO2006068326A1 Novel polypeptide and the use thereof
06/29/2006WO2006067462A1 1,6 - substituted (3r,6r) -3- (2,3-dihydro-1h-inden-2-yl)-2,5-piperazinedione derivatives as oxytocin receptor antagonists for the treatment of pre-term labour, dysmenorrhea and endometriosis
06/29/2006US20060142333 e.g. N-(1-Methyl-1,2,3,4-tetrahydroquinolin-7-yl)-1,1'-biphenyl-4-carboxamide; capsaicin recepor antagonist; analgesic; neuropathic, postoperative, postrheumatoid arthritic, back, cancer pain, neuralgia, dental pain, headache, migraine, diabetic and HIV-related neuropathy
06/29/2006US20060142314 2-substituted-4-(indazol-5-ylamino)-6,7-dimethoxyquinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction
06/29/2006US20060142313 2-substituted-4-(indazolamino)quinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction
06/29/2006US20060142306 Bronchodilator agents; respiratory system disorders; skin disorders ; asthma; hypotensive agents
06/29/2006US20060142280 Such as 4-(4,4-Dimethyl-2-thioxo-1,4-dihydro-2H-benzo[d][1 ,3]oxazin-6-yl)-thiophene-2-carbonitrile; estrogen receptor agonists, progesterone receptor antagonists; hormone replacement therapy
06/29/2006US20060142267 [6-hydroxy-2-(2-hydroxy-benzyl)-benzo [b]thiophen-3-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone; [6-hydroxy-2-(2-hydroxy-benzyl)-naphthalen-1-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone; 6-(2-hydroxy-benzyl)-5-{hydroxy-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methyl}-naphthalen-2-ol
06/29/2006US20060142258 Estrogen replacement therapy
06/29/2006US20060142256 Composition comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometricosis
06/29/2006US20060142243 Promoting repair of skin and mucous membrane tissues, the product of the present invention exhibits unique effects for controlling inflammation, damage, infection, and exudation; side effect reduction; topical administration
06/29/2006US20060141579 Cytokine zcytor17 ligand polynucleotides
06/29/2006US20060141444 Adherent entities and uses therefor
06/29/2006US20060141071 Compositions and methods for treating gynecological disorders
06/29/2006US20060141032 Effervescent formulations comprising apomorphine
06/29/2006US20060140954 Novel human protein kinases and protein kinase-like enzymes
06/29/2006US20060140907 Central airway administration for systemic delivery of therapeutics
06/29/2006DE202006000605U1 Preparation, for use as e.g. fodder and to stimulate growth, comprises dextrose and powder and/or aqueous/alcoholic extracts of whole plants/plant parts of e.g. Piper nigrum, Glycyrrhiza glabra, Zingiber officinale and Withania ashwagandha
06/29/2006CA2592201A1 Neuromedin s and the use thereof
06/29/2006CA2591827A1 1,6 - substituted (3r,6r) -3- (2,3-dihydro-1h-inden-2-yl)-2,5-piperazinedione derivatives as oxytocin receptor antagonists for the treatment of pre-term labour, dysmenorrhea and endometriosis
06/28/2006EP1674452A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor
06/28/2006EP1674102A1 Use of flibanserin in the treatment of sexual disorders
06/28/2006EP1673353A1 Transition state structure and inhibitors of thymidine phosphorylases
06/28/2006EP1673105A1 Use of follicle stimulating hormone for reduction of spermatozoa chromosomal aberration in males
06/28/2006EP1673094A1 Extended triphasic contraceptive regimens
06/28/2006EP1268783B1 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon
06/28/2006EP1267901B9 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress
06/28/2006EP1259243B1 Bupropion metabolites and methods of their synthesis and use
06/28/2006EP1255536B1 Indolinone derivatives for modulation of c-kit tyrosine protein kinase
06/28/2006EP1121372B1 Adenine derivatives
06/28/2006EP1107762B9 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure sexual dysfunction in women
06/28/2006CN1794974A 药物递送体系 Drug delivery system
06/28/2006CN1792248A Cooked meat with donkey-hide gelatin for health-care, moistening-skin, improving-immunity, benefit to brain and retarding-senium
06/28/2006CN1261437C Glycine-substituted thieno 2,3-d]pyrimidines with combined LH and FSH agonistic activity
06/28/2006CN1261431C 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
06/28/2006CN1261412C Indole derivatives as COXII inhibitors
06/28/2006CN1261147C Chinese medicinal preparation for treating climacteric syndrome of qi and blood deficiency type and preparing process thereof
06/28/2006CN1261146C Traditional Chinese medicine preparation for treating hyperplasia of mammary glands
06/28/2006CN1261099C Tetrahydroquinoline derivatives
06/27/2006US7067554 Method for the synthesis of compounds of formula I and their uses thereof
06/27/2006US7067543 Anthranilic acid amides and pharmaceutical use thereof
06/27/2006US7067540 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders
06/27/2006US7067537 Anticancer, antitumor agents
06/27/2006US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same
06/27/2006US7067524 estrogen receptor agaonists or antagonists; therapy or prophylaxis for endometriosis; 8-fluoro-6-(3-fluoro-4-hydroxyphenyl)-2-naphthol
06/27/2006US7067510 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss
06/27/2006US7067503 17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
06/27/2006US7067162 Use of odorants to alter blood flow to the vagina
06/27/2006US7067114 Delivery of antihistamines through an inhalation route
06/27/2006CA2408909C Azabicyclo[3.2.1]octane triazolyl tropane derivatives as ccrs5 modulators
06/22/2006WO2006065706A1 N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto
06/22/2006WO2006065555A2 Use of alpha-adrenergic blockers for the treatment of dysmenorrhea
06/22/2006WO2006065309A1 Use of polyethylene oxide for urogenital infection inhibition
06/22/2006WO2006026380A3 Geranylgeranyl pyrophosphate synthase inhibitors
06/22/2006WO2003061655A8 2-aminothiazole allosteric enhancers of a1 adenosine receptors
06/22/2006US20060135611 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function
06/22/2006US20060135606 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
06/22/2006US20060135590 Selected fused pyrrolocarbazoles
06/22/2006US20060135555 Ring fused pyrazole derivatives as CRF antagonists
06/22/2006US20060135534 Pyrazine based inhibitors of glycogen synthase kinase 3
06/22/2006US20060135531 Modulators of dopamine neurotransmission
06/22/2006US20060135421 Unitary combination of FSH and hCG
06/22/2006US20060135415 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
06/22/2006US20060134688 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets
06/22/2006US20060134232 Herbal supplement for cognitive related impairment due to estrogen loss
06/22/2006DE102004060752A1 New heteroaryloxy-substituted phenylamino pyrimidine compounds are Rho-kinase inhibitors useful for the treatment and/or prophylaxis of cardiovascular diseases e.g. myocardial infarction and arrhythmia, erectile dysfunction and cancers
06/22/2006CA2588567A1 N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto
06/22/2006CA2588017A1 Use of alpha-adrenergic blockers for the treatment of dysmenorrhea
06/21/2006EP1671628A1 Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
06/21/2006EP1670322A1 Extract of ogalpi, erectile dysfunction fanning healthy food and erectile dysfunction treating agent containing the same
06/21/2006EP1506193B1 Carbamate-substituted pyrazolopyridines
06/21/2006EP1423147B1 Prostaglandin compositions and methods of treatment for male erectile dysfunction
06/21/2006EP1366049B1 Pirazino¬1'2':1,6|pyrido¬3,4-b|indole derivatives
06/21/2006EP1365766B1 Pharmaceutical composition for treatment of phimosis using topical corticosteroid